Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

Bp Consulting, Inc50 enrolled

Overview

The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Comfort, Vision and Wear Time

Interventions

New PEG based artificial tearDRUG

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

OptiveDRUG

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Use of soft contact lenses (e.g. silicone hydrogel lenses, daily disposables etc.) and multipurpose solution for cleaning, including enzyme-based cleaners (ClearCare etc.) * Able to wear contact lenses for approximately 10-12 hours/day * Willingness to complete entire length of trial and comply with subjective questionnaire. Exclusion Criteria: * Patients taking topical cyclosporine (Restasis) * Patients currently using Optive for dryness relief. * Patients wearing hard or rigid gas permeable lenses * Patients with uncontrolled systemic disease which may confound the results of the trial.

Locations (1)

The New York Presbyterian Hospital-Weill Cornell Medical College

New York, New York, United States

Outcomes

Primary Outcomes

Comfort

Time frame: 1 month

Secondary Outcomes

vision and wear time

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.